Table 2.

Effect of adrenergic receptor activation on IPSC amplitude.

Recording condition	Control amplitude (pA)	NE/agonist amplitude (pA)	t	df	p	% of control	t	df	p
sIPSCs NE (KCl int.)	48.04 ± 5.54	71.90 ± 8.12	3.2	12	0.008∗	167.04 ± 30.27	2.22	12	0.047∗
sIPSCs NE	57.90 ± 9.34	80.61 ± 11.57	4.61	12	0.0006∗	148.99 ± 12.66	3.87	12	0.002∗
mIPSCs NE	41.35 ± 1.82	42.20 ± 2.06	1.24	18	0.23	101.94 ± 1.77	1.1	18	0.29
sIPSCs PHE	57.09 ± 4.02	60.66 ± 9.19	0.48	9	0.64	105.49 ± 11.68	0.47	9	0.65
mIPSCs PHE	31.90 ± 2.52	30.28 ± 3.75	1.1	5	0.32	93.32 ± 5.65	1.18	5	0.29
sIPSCs UK14304	59.81 ± 8.84	53.55 ± 3.98	0.78	6	0.47	97.62 ± 9.87	0.24	6	0.82
mIPSCs UK14304	39.81 ± 1.75	38.91 ± 2.27	0.7	5	0.52	97.59 ± 2.56	0.81	5	0.45
sIPSCs Isoprenaline	59.74 ± 6.50	59.52 ± 10.39	0.03	4	0.98	97.77 ± 9.00	0.2	4	0.85
mIPSCs Isoprenaline	35.78 ± 1.18	35.92 ± 1.25	0.12	6	0.91	100.63 ± 3.17	0.20	6	0.85

^∗p < 0.05.